In-Principle Approval | |||||||
| Name of Company* | Neogen Chemicals Limited | ||||||
| ISIN* | INE136S01016 | ||||||
| Corporate Identity Number (CIN) of the Listed Entity* | L24200MH1989PLC050919 | ||||||
| Permanent Account Number (PAN)* | AAACN5836E | ||||||
| BSE Scrip code* | 542665 | ||||||
| NSE Symbol | NEOGEN | ||||||
| MSEI Symbol | NOTLISTED | ||||||
| Board resolution approving the issue of specified securities * | 07-03-2026 | ||||||
| Object of the Issue (As per Notice/offer document) * | |||||||
| Category of Allottee* | Promoter | ||||||
Detials of security | |||||||
| Security Type | Number of securities | Amount to be raised ( Rs in Lakhs) | Relavent Date | Minimum Issue Price (per security) | Terms of Payment in % (100/25/other specify) | ||
| DD | MM | YYYY | |||||
| Equity Shares | 1000000 | 16100 | 27 | 02 | 2026 | 1610 | 100 |
| Total amount to be raised ( Rs in Lakhs) | 16100 | ||||||
| Consideration* | Cash | ||||||
| Description of other consideration | |||||||
| Details of allottes* | |||||||
| Date Of Submission | 24-03-2026 | ||||||
| Notes | Mr. Haridas Kanani and Mrs. Beena Haridas Kanani, the members of promoter and promoter group of the Company have done inter se transfer of equity shares by way of gift to their respective Trust on 31-12-2025 pursuant to an exemption order passed by SEBI on December 30, 2025 bearing reference number WTM/ KCV/ CFD/ 17/2025-26 and the said inter-se transfers was during the 90 trading days preceding the Relevant Date and hence the proposed allottee Cadamba Solutions Private Limited who is also a promoter group member of the Company w.e.f. 15-12-2025, has made an application to SEBI pursuant to regulation 300 of SEBI ICDR regulations seeking exemption from strict application of regulation 159 read with explanation thereof of the SEBI ICDR regulations.The allotment of the said equity shares shall be subject to the Order being passed by SEBI in this matter. | ||||||
Details of allottes | |||
| Sr. | Name of allottes | Security type | No of securities to be allotted |
| 1 | Cadamba Solutions Private Limited | Equity Shares | 1000000 |
Object of the Issue | ||
| Sr. | Object | Details of the object |
| 1 | Investment in Neogen Ionics Limited -a wholly owned subsidiary of Neogen Chemicals Limited | Amount in Rs. In Crores: 80 - 100, Utilisation timeline: Up to 90 days, There may be variation not exceeding +/- 10% in the estimated amounts specified against each of the objects. |
| 2 | Meeting Working capital requirements | Amount in Rs. In Crores: 21 - 41, Utilisation timeline: Up to 90 days, There may be variation not exceeding +/- 10% in the estimated amounts specified against each of the objects. |
| 3 | General corporate purposes | Amount in Rs. In Crores: 40, Utilisation timeline: Up to 90 days, There may be variation not exceeding +/- 10% in th e estimated amounts specified against each of the objects. The amount utilized for general corporate purpose shall not exceed 25% of the Gross Proceeds. Further, the fund requirements are based on internal management estimates and have not been appraised by any bank, financial institution or any other external agency. They are based on current circumstances of our business. The Company may have to revise its estimates from time to time on account of various factors beyond its control, such as financial, market and sectoral conditions, competitive environment, business performance and strategy and interest or exchange rate fluctuations. Consequently, the funding requirements of our Company and deployment schedules are subject to revision in the future at the discretion of the management. Pending utilization of the proceeds from the Preferential Issue, the Company shall invest such proceeds in money market instruments including money market mutual funds, deposits in scheduled commercial banks or any other investment as permitted under applicable laws. |